文献速递肺外科

预测IIIA-N2期非小细胞肺癌术后生存的列线图

A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-12-20

本研究基于监测、流行病学和最终结果数据库2004年1月至2009年12月的回顾性数据,纳入1809例接受手术的IIIA-N2期非小细胞肺癌患者构建列线图,并在江苏省肿瘤医院肺癌中心独立队列中验证。模型一致性指数在训练队列为0.673(95%CI 0.654-0.692),验证队列为0.664(95%CI 0.614-0.714),校准图显示预测生存与实际生存一致性良好。

要点

  • 年龄、性别、分级、组织学、肿瘤大小、脏层胸膜侵犯、阳性淋巴结数、检查淋巴结数及手术方式被识别为显著预后变量。
  • 列线图在训练队列一致性指数0.673(95%CI 0.654-0.692),验证队列0.664(95%CI 0.614-0.714)。
  • 按预后评分分层的亚组间生存差异显著。

核心结论

  • 该列线图可为IIIA-N2期非小细胞肺癌术后患者提供个体化生存预测,可能有助于患者和临床医生的生存咨询、临床试验设计及随访以及术后策略制定。

研究设计与样本

  • 回顾性分析监测、流行病学和最终结果数据库2004年1月至2009年12月数据,训练队列纳入1809例接受手术的IIIA-N2期非小细胞肺癌患者,采用后向逐步法筛选变量,多变量Cox回归构建列线图,并通过江苏省肿瘤医院肺癌中心独立队列验证。

主要发现

  • 年龄、性别、分级、组织学、肿瘤大小、脏层胸膜侵犯、阳性淋巴结数、检查淋巴结数及手术方式(肺叶切除 vs 全肺切除)被后向逐步法识别为显著预后变量。
  • 模型一致性指数在训练队列为0.673(95%CI 0.654-0.692),在验证队列为0.664(95%CI 0.614-0.714)。
  • 校准图显示列线图预测生存与实际生存之间一致性最佳。
  • 按预后评分分层的不同亚组间生存分析显示显著差异。

临床怎么用

  • 原文结论指出该列线图可能有助于患者和临床医生的生存咨询、临床试验设计及随访以及术后策略制定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Postoperative survival of patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) is highly heterogeneous. Here, we aimed to identify variables associated with postoperative survival and develop a tool for survival prediction. METHODS: A retrospective review was performed in the Surveillance, Epidemiology, and End Results database from January 2004 to December 2009. Significant variables were selected by use of the backward stepwise method. The nomogram was constructed with multivariable Cox regression. The model's performance was evaluated by concordance index and calibration curve. The model was validated via an independent cohort from the Jiangsu Cancer Hospital Lung Cancer Center. RESULTS: A total of 1809 patients with stage IIIA-N2 NSCLC who underwent surgery were included in the training cohort. Age, sex, grade, histology, tumor size, visceral pleural invasion, positive lymph nodes, lymph nodes examined, and surgery type (lobectomy vs pneumonectomy) were identified as significant prognostic variables using backward stepwise method. A nomogram was developed from the training cohort and validated using an independent Chinese cohort. The concordance index of the model was 0.673 (95% confidence interval, 0.654-0.692) in training cohort and 0.664 in validation cohort (95% confidence interval, 0.614-0.714). The calibration plot showed optimal consistency between nomogram predicted survival and observed survival. Survival analyses demonstrated significant differences between different subgroups stratified by prognostic scores. CONCLUSIONS: This nomogram provided the individual survival prediction for patients with stage IIIA-N2 NSCLC after surgery, which might benefit survival counseling for patients and clinicians, clinical trial design and follow-up, as well as postoperative strategy-making.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Mao Q, Xia W, Dong G, et al. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. J Thorac Cardiovasc Surg. 2017. PMID: 29554790. doi:10.1016/j.jtcvs.2017.11.098

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。